Blockade of IL-7 signaling suppresses inflammatory responses and reverses alopecia areata in C3H/HeJ mice.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33811067.
- Also identified by DOI 10.1126/sciadv.abd1866 and PMC identifier 11060042.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The interleukin-7 (IL-7) signaling pathway plays an important role in regulation of T cell function and survival. We detected overexpression of IL-7 in lesional skin from both humans and C3H/HeJ mice with alopecia areata (AA), a T cell-mediated autoimmune disease of the hair follicle. We found that exogenous IL-7 accelerated the onset of AA by augmenting the expansion of alopecic T cells. Conversely, blockade of IL-7 stopped the progression of AA and reversed early AA in C3H/HeJ mice. Mechanistically, we observed that IL-7Rα blockade substantially reduced the total number of most T cell subsets, but relative sparing of regulatory T cells (T<sub>regs</sub>). We postulated that short-term anti-IL-7Rα treatment in combination with a low dose of T<sub>reg</sub>-tropic cytokines might improve therapeutic efficacy in AA. We demonstrated that short-term IL-7Rα blockade in combination with low doses of T<sub>reg</sub>-tropic cytokines enhanced therapeutic effects in the treatment of AA, and invite further clinical investigation.